Tejnaksh Healthcare Ltd

Company Profile

Tejnaksh Healthcare Ltd had its IPO on under the ticker symbol TEJNAKSH.

The company operates in the sector and industry. Tejnaksh Healthcare Ltd has a staff strength of 0 employees.

Stock update

Shares of Tejnaksh Healthcare Ltd opened at ₹34 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹33.01 - ₹34.44, and closed at ₹33.45.

This is a -2.48% slip from the previous day's closing price.

A total volume of 15,382 shares were traded at the close of the day’s session.

In the last one week, shares of Tejnaksh Healthcare Ltd have slipped by -2.48%.

Tejnaksh Healthcare Ltd's Key Ratios

Tejnaksh Healthcare Ltd has a market cap of ₹781.97 million, indicating a price to book ratio of 5.3206 and a price to sales ratio of 9.1898.

In the last 12-months Tejnaksh Healthcare Ltd’s revenue was ₹0 with a gross profit of ₹133.45 million and an EBITDA of ₹0. The EBITDA ratio measures Tejnaksh Healthcare Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Tejnaksh Healthcare Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 1302.07%.

In Q4, Tejnaksh Healthcare Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Tejnaksh Healthcare Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

55.0322

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tejnaksh Healthcare Ltd’s profitability.

Tejnaksh Healthcare Ltd stock is trading at a EV to sales ratio of 9.378 and a EV to EBITDA ratio of 23.2924. Its price to sales ratio in the trailing 12-months stood at 9.1898.

Tejnaksh Healthcare Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹312.60 million

Total Liabilities

₹17.49 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Tejnaksh Healthcare Ltd ended 2024 with ₹312.60 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹312.60 million while shareholder equity stood at ₹214.66 million.

Tejnaksh Healthcare Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹17.49 million in other current liabilities, 101568000.00 in common stock, ₹113.10 million in retained earnings and ₹35.00 million in goodwill. Its cash balance stood at ₹18.22 million and cash and short-term investments were ₹37.69 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹61.13 million.

Tejnaksh Healthcare Ltd’s total current assets stands at ₹60.88 million while long-term investments were ₹0 and short-term investments were ₹6.24 million. Its net receivables were ₹10.12 million compared to accounts payable of ₹4.97 million and inventory worth ₹7.88 million.

In 2024, Tejnaksh Healthcare Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Tejnaksh Healthcare Ltd paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹33.45

52-Week High

₹172.85

52-Week Low

₹58.99

Analyst Target Price

₹

Tejnaksh Healthcare Ltd stock is currently trading at ₹33.45 per share. It touched a 52-week high of ₹172.85 and a 52-week low of ₹172.85. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹34.36 and 200-day moving average was ₹43.01 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.